Drug Shortage Report for AURO-TENOFOVIR

Last updated on 2024-11-14 History
Report ID 217670
Drug Identification Number 02460173
Brand name AURO-TENOFOVIR
Common or Proper name AURO-TENOFOVIR
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) TENOFOVIR DISOPROXIL FUMARATE
Strength(s) 300MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 30's
ATC code J05AF
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2024-01-29
Estimated end date 2024-11-15
Actual end date 2024-11-13
Shortage status Resolved
Updated date 2024-11-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2024-11-14 English Compare
v13 2024-11-13 French Compare
v12 2024-11-13 English Compare
v11 2024-10-25 French Compare
v10 2024-10-25 English Compare
v9 2024-10-11 French Compare
v8 2024-10-11 English Compare
v7 2024-09-27 French Compare
v6 2024-09-27 English Compare
v5 2024-03-27 French Compare
v4 2024-03-27 English Compare
v3 2024-01-30 English Compare
v2 2024-01-29 French Compare
v1 2024-01-29 English Compare

Showing 1 to 14 of 14